The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Calcineurin Negatively Regulates TLR-Mediated Activation Pathways
Open accessAbstract
In innate immunity, microbial components stimulate macrophages to produce antimicrobial substances, cytokines, other proinflammatory mediators, and IFNs via TLRs, which trigger signaling pathways activating NF-κB, MAPKs, and IFN response factors. We show in this study that, in contrast to its activating role in T cells, in macrophages the protein phosphatase calcineurin negatively regulates NF-κB, MAPKs, and IFN response factor activation by inhibiting the TLR-mediated signaling pathways. Evidence for this novel role for calcineurin was provided by the findings that these signaling pathways are activated when calcineurin is inhibited either by the inhibitors cyclosporin A or FK506 or by small interfering RNA-targeting calcineurin, and that activation of these pathways by TLR ligands is inhibited by the overexpression of a constitutively active form of calcineurin. We further found that IκB-α degradation, MAPK activation, and TNF-α production by FK506 were reduced in macrophages from mice deficient in MyD88, Toll/IL-1R domain-containing adaptor-inducing IFN-β (TRIF), TLR2, or TLR4, whereas macrophages from TLR3-deficient or TLR9 mutant mice showed the same responses to FK506 as those of wild-type cells. Biochemical studies indicate that calcineurin interacts with MyD88, TRIF, TLR2, and TLR4, but not with TLR3 or TLR9. Collectively, these results suggest that calcineurin negatively regulates TLR-mediated activation pathways in macrophages by inhibiting the adaptor proteins MyD88 and TRIF, and a subset of TLRs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Many of these pathways involve calcium signaling, and the calcineurin cascade which in macrophages has been shown to down-regulate TLR mediated activation pathways [43].”
From Alzheimer’s disease-associated protective variant Plcg2-P522R modulates peripheral macrophage function in a sex-dimorphic manner (2024) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,976
Self-citationJaneway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Self-citationA Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 16×
“Mice, cell culture, and transfections Thioglycolate-elicited peritoneal macrophages from wild-type mice, mice deficient in MyD88, TRIF, TLR2, TLR3, or TLR4, or from TLR9 mutant TLR9CpG1/CpG1 mice (provided to J. Han by B. Beutler, The Scripps Research Institute, La Jolla, CA) were aseptically harvested.”
BackgroundInfluentialSelf-citationRecognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Self-citationThe innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
Hayashi, F., Smith, K. D., Ozinsky, A., Hawn, T. R., Yi, E. C., Goodlett, D. R., Eng, J. K., Akira, S., Underhill, D. M., & Aderem, A. A. (2001) · Nature · doi:10.1038/35074106 · Cited by 3,605
Self-citationRole of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., et al. (2003) · Science · doi:10.1126/science.1087262 · Cited by 3,286
Self-citationSmall anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,577
Self-citationA cytokine-responsive IκB kinase that activates the transcription factor NF-κB
DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., & Karin, M. (1997) · Nature · doi:10.1038/41493 · Cited by 2,125
Research works printed but not linked: 61
- 2002, Annu. Rev. Immunol., 197
- 2004, Nat. Rev. Immunol., 499
- 2004, Nature, 257
- 2000, Curr. Opin. Immunol., 13
- 2000, J. Immunol., 5780
- 1999, Science, 736
- 2000, Nature, 740
- 2001, Nature, 1099
- 2001, Nature, 732
- 2004, Science, 1526
- 2002, Nat. Immunol., 196
- 2001, Biochim. Biophys. Acta, 157
- 2004, Science, 1522
- 2006, Cell, 783
- 2005, Nat. Immunol., 1198
- 2003, Mol. Cell, 293
- 1997, Immunity, 837
- 1996, Science, 1128
- 2002, Proc. Natl. Acad. Sci. USA, 5567
- 1996, Nature, 443
- 1998, J. Exp. Med., 2097
- 1997, Nature, 548
- 1997, Cell, 243
- 1998, Science, 1360
- 2002, Annu. Rev. Immunol., 55
- 2001, J. Immunol., 5887
- 2002, Immunity, 251
- 2003, Science, 640
- 2003, Nature, 743
- 2000, Physiol. Rev., 1483
- 2006, Immunity, 141
- 1995, J. Exp. Med., 1091
- 1994, EMBO J., 861
- 1999, Proc. Natl. Acad. Sci. USA, 6324
- 2006, J. Biol. Chem., 26225
- 1999, J. Biol. Chem., 34657
- 2002, Int. Immunol., 783
- 2000, J. Biol. Chem., 11728
- 1997, EMBO J., 1080
- 2000, Immunity, 419
- 2002, Nature, 750
- 1994, J. Exp. Med., 763
- 2004, Am. J. Pathol., 1755
- 1996, J. Exp. Med., 413
- 2002, Eur. J. Immunol., 1223
- 2002, Proc. Natl. Acad. Sci. USA, 9398
- 2001, Arch. Biochem. Biophys., 243
- 2001, Biochem. J., 351
- 2003, Eur. J. Immunol., 597
- 1997, Soc. Gen. Physiol. Ser., 227
- 2004, Biochem. J., 1
- 2001, Curr. Opin. Crit. Care, 384
- 2004, Transplantation, 338
- 2000, Diabetes, 1561
- 2001, Biochem. Biophys. Res. Commun., 968
- 1999, Transplantation, 1746
- 2000, J. Immunol., 2271
- 1994, Blood, 2570
- 1997, Nephrol. Dial. Transplant., 2687
- 1996, J. Clin. Invest., 2433
- 2003, Kidney Int., 306
Cited by
Sorted by citations
Signalling through C-type lectin receptors: shaping immune responses
Geijtenbeek, T. B. H., & Gringhuis, S. I. (2009) · Nature reviews. Immunology · doi:10.1038/nri2569 · Cited by 1,449
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
Kumar, V. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107087 · Cited by 285
Lowell, C. A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002352 · Cited by 277
NFAT control of innate immunity
Frič, J., Zelante, T., Wong, A. Y. W., Mertes, A., Yu, H.-B., & Ricciardi‐Castagnoli, P. (2012) · Blood · doi:10.1182/blood-2012-02-404475 · Cited by 248
Cross-regulation of signaling by ITAM-associated receptors
Ivashkiv, L. B. (2009) · Nature Immunology · doi:10.1038/ni.1706 · Cited by 219
A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetes
Lim, H. J., Lim, Y.-M., Kim, K. H., Jeon, Y. E., Park, K., Kim, J., Hwang, H., Lee, D., Pagire, H. S., Kwon, H. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03939-w · Cited by 164
Rodrigues‐Díez, R., González‐Guerrero, C., Ocaña-Salceda, C., Rodrigues-Díez, R. R., Egido, J., Ortíz, A., Ruiz‐Ortega, M., & Ramos, A. M. (2016) · Scientific Reports · doi:10.1038/srep27915 · Cited by 124
Riad, A., Jäger, S., Sobirey, M., Escher, F., Yaulema-Riss, A., Westermann, D., Karatas, A., Heimesaat, M. M., Bereswill, S., Dragun, D., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6954 · Cited by 120
Kelly, E., Wang, L., & Ivashkiv, L. B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901293 · Cited by 99
The divergent roles of macrophages in solid organ transplantation
Salehi, S., & Reed, E. F. (2015) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000209 · Cited by 89
Kim, J., Shin, J., Ryu, J. H., Kim, S. Y., Cho, Y., Choi, J., & Lee, K. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.04.009 · Cited by 86
McCoy, C. E., Carpenter, S., Pålsson-McDermott, E. M., Gearing, L. J., & O'Neill, L. A. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709731200 · Cited by 82
A signal-switch hypothesis for cross-regulation of cytokine and TLR signalling pathways
Ivashkiv, L. B. (2008) · Nature reviews. Immunology · doi:10.1038/nri2396 · Cited by 81
Targeting the Monocyte–Macrophage Lineage in Solid Organ Transplantation
van den Bosch, T. P. P., Kannegieter, N. M., Hesselink, D. A., Baan, C. C., & Rowshani, A. T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00153 · Cited by 82
Vilariño‐Güell, C., Zimprich, A. A., Boneschi, F. M., Herculano, B., Wang, Z., Matesanz, F., Urcelay, E., Vandenbroeck, K., Leyva, L., Gris, D., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008180 · Cited by 79
Nguyen, L., & Pieters, J. (2009) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061008-103123 · Cited by 78
Bendíčková, K., Tidu, F., & Frič, J. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707698 · Cited by 65
Tacrolimus- and sirolimus-induced human β cell dysfunction is reversible and preventable
Dai, C., Walker, J. T., Shostak, A., Padgett, A., Spears, E., Wisniewski, S., Poffenberger, G., Aramandla, R., Dean, E. D., Prasad, N., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.130770 · Cited by 64
Hidalgo, A., García-Mouton, C., Autilio, C., Carravilla, P., Orellana, G., Islam, M. N., Bhattacharya, J., Bhattacharya, S., Cruz, A., & Pérez‐Gil, J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.042 · Cited by 63
Ge, Y., Xu, Y., Sun, W., Man, Z., Zhu, L., Xia, X., Zhao, L., Zhao, Y., & Wang, X. (2012) · Gene · doi:10.1016/j.gene.2012.07.045 · Cited by 62
Calcineurin/NFAT signaling and innate host defence: a role for NOD1-mediated phagocytic functions
Vandewalle, A., Tourneur, E., Bens, M., Chassin, C., & Werts, C. (2014) · Cell Communication and Signaling · doi:10.1186/1478-811x-12-8 · Cited by 62
Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease
Nakagawa, N., Barron, L., Gomez, I. G., Johnson, B. G., Roach, A. M., Kameoka, S., Jack, R. M., Lupher, M. L., Gharib, S. A., & Duffield, J. S. (2016) · JCI Insight · doi:10.1172/jci.insight.87446 · Cited by 59
Jennings, C., Kusler, B., & Jones, P. P. (2009) · Innate Immunity · doi:10.1177/1753425908100928 · Cited by 59
Self-citationRBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis
Li, S., Miller, C. H., Γιαννοπούλου, Ε., Hu, X., Ivashkiv, L. B., & Zhao, B. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71882 · Cited by 59
Minematsu, H., Shin, M., Celil, A. B., Kim, K.-O., Nizami, S. A., Chung, G.-J., & Lee, F. Y. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.06.013 · Cited by 57
Cyclosporin A and atherosclerosis — Cellular pathways in atherogenesis
Kockx, M., Jessup, W., & Kritharides, L. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.06.001 · Cited by 57
Howell, J. A., Sawhney, R., Testro, A., Skinner, N. A., Gow, P. J., Angus, P., Ratnam, D. T., & Visvanathan, K. (2013) · Liver Transplantation · doi:10.1002/lt.23712 · Cited by 55
Lee, S.-M., Choi, S., Lee, J., Lee, J., Jung, I., Lee, S., Lee, K. W., & KANG, Y. Y. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0820-7 · Cited by 51
Self-citationTourneur, E., Mkaddem, S. B., Chassin, C., Bens, M., Goujon, J., Charles, N., Pellefigues, C., Aloulou, M., Hertig, A., Monteiro, R. C., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003152 · Cited by 52
Hirsch, I., Janovec, V., Stránská, R., & Bendriss‐Vermare, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00394 · Cited by 50
Role of donor macrophages after heart and lung transplantation
Kopecky, B. J., Frye, C. C., Terada, Y., Balsara, K. R., Kreisel, D., & Lavine, K. J. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15751 · Cited by 49
Lai, D., Wan, M., Wu, J., Preston‐Hurlburt, P., Kushwaha, R., Grundström, T., Imbalzano, A. N., & Chi, T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811274106 · Cited by 48
González‐Guerrero, C., Ocaña-Salceda, C., Berzal, S., Carrasco, S., Fernández‐Fernández, B., Cannata‐Ortiz, P., Egido, J., Ortíz, A., & Ramos, A. M. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.08.011 · Cited by 45
Blockade of microglial Cav1.2 Ca2+ channel exacerbates the symptoms in a Parkinson’s disease model
Wang, X., Saegusa, H., Huntula, S., & Tanabe, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-45681-3 · Cited by 45
Shin, J., Cho, E.-J., Choi, H., Seo, J., An, H., Park, H.-J., Cho, Y., & Lee, K. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.10.044 · Cited by 44
Insights into the modulatory role of cyclosporine A and its research advances in acute inflammation
Gui, Q., Jiang, Z., & Zhang, L. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107420 · Cited by 41
Huang, H., Xiong, Q., Wang, N., Chen, R., Ren, H., Siwko, S. K., Han, H., Liu, M., Qian, M., & Du, B. (2018) · Science Advances · doi:10.1126/sciadv.aas9784 · Cited by 38
A new and clinically relevant murine model of solid-organ transplant aspergillosis
Herbst, S., Shah, A., Carby, M. R., Chusney, G. D., Naresh, K. N., Dorling, A., Bignell, E., Shaunak, S., & Armstrong-James, D. P. H. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010330 · Cited by 40
Pajarinen, J., Lin, T., Sato, T., Loi, F., Yao, Z., Konttinen, Y. T., & Goodman, S. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142736 · Cited by 34
Protein phosphatases in TLR signaling
Seumen, C. H. T., Grimm, T. M., & Hauck, C. R. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00722-1 · Cited by 34
Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection
Emal, D., Rampanelli, E., Claessen, N., Bemelman, F. J., Leemans, J. C., Florquin, S., & Dessing, M. C. (2019) · Scientific Reports · doi:10.1038/s41598-018-37482-x · Cited by 33
Zelante, T., Wong, A. Y. W., Mencarelli, A., Foo, S., Zolezzi, F., Lee, B., Poidinger, M., Ricciardi-Castagnoli, P., & Fric, J. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.52 · Cited by 32
TLR4 Promotes B Cell Maturation: Independence and Cooperation with B Lymphocyte-Activating Factor
Hayashi, E. A., Granato, A., de Paiva, L. S., Bertho, Á. L., Bellio, M., & Nóbrega, A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903253 · Cited by 32
Geldanamycin accelerated peripheral nerve regeneration in comparison to FK-506 in vivo
Sun, H. H., Saheb-Al-Zamani, M., Yan, Y., Hunter, D. A., Mackinnon, S. E., & Johnson, P. J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.026 · Cited by 32
Cyclosporin A and Phenytoin Modulate Inflammatory Responses
Suzuki, A., Yoshimura, A., Ozaki, Y., Kaneko, T., & Hara, Y. (2009) · Journal of Dental Research · doi:10.1177/0022034509350566 · Cited by 32
Specific calcineurin targeting in macrophages confers resistance to inflammation via MKP‐1 and p38
Escolano, A., Martı́nez-Martı́nez, S., Alfranca, A., Urso, K., Izquierdo, H. M., Delgado, M., Martı́n, F., Sabio, G., Sancho, D., Arco, P. G., et al. (2014) · The EMBO Journal · doi:10.1002/embj.201386369 · Cited by 31
Ca2+‐related signaling events influence TLR9‐induced IL‐10 secretion in human B cells
Ziegler, S., Gartner, K., Scheuermann, U., Zoeller, T., Hantzschmann, J., Over, B., Foermer, S., Heeg, K. M., & Bekeredjian‐Ding, I. (2014) · European Journal of Immunology · doi:10.1002/eji.201343994 · Cited by 33
Shin, J., Baek, S. R., Sohn, S. I., Cho, Y., & Lee, K. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23290 · Cited by 30
Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways
Pang, Z., Junkins, R. D., Raudonis, R., MacNeil, A. J., McCormick, C., Cheng, Z., & Lin, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197491 · Cited by 29
Functionally Distinct Subpopulations of CpG-Activated Memory B Cells
Henn, A. D., Laski, M., Yang, H., Welle, S. L., Qiu, X., Miao, H., Barry, C. T., Wu, H., & Zand, M. S. (2012) · Scientific Reports · doi:10.1038/srep00345 · Cited by 28
Means, T. K., & Luster, A. D. (2010) · Nature Immunology · doi:10.1038/ni0810-691 · Cited by 28
Role of toll-like receptors in liver transplantation
Howell, J. A., Gow, P. J., Angus, P., & Visvanathan, K. (2013) · Liver Transplantation · doi:10.1002/lt.23793 · Cited by 26
Ho, H.-J., Huang, D.-Y., Ho, F., Lee, L., & Lin, W. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.07.018 · Cited by 24
Kiely, A. P., Robinson, A. A., McClenaghan, N. H., Flatt, P. R., & Newsholme, P. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0160 · Cited by 23
Zhou, X., He, Z., Henegar, J., Allen, B. C., & Bigler, S. A. (2010) · Cardiovascular Pathology · doi:10.1016/j.carpath.2010.08.002 · Cited by 19
Calcium regulates caveolin-1 expression at the transcriptional level
Yang, X.-Y., Huang, C.-C., Kan, Q.-M., Li, Y., Liu, D., Zhang, X.-C., Sato, T., Yamagata, S., & Yamagata, T. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.079 · Cited by 19
Nitric Oxide-Induced Calcineurin A Mediates Antimicrobial Peptide Production Through the IMD Pathway
Chen, K., Wang, X., Wei, X., Chen, J., Wei, Y., Jiang, H., Lu, Z., & Feng, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.905419 · Cited by 19
Suppression of Calcineurin Enhances the Toxicity of Cry1Ac to Helicoverpa armigera
Wei, J., Yao, X., Yang, S., Liu, S., Zhou, S., Cen, J., Liu, X., Du, M., Tang, Q., & An, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.634619 · Cited by 17
Hendricks, A., Elson-Riggins, J. G., Riddle, A., House, A. K., Varjonen, K., & Bond, R. (2012) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2012.03.010 · Cited by 16
Shin, J., Choi, H., Kim, S.-D., Lee, Y. S., Cho, Y., & Lee, K. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.10.004 · Cited by 15
Yang, J.-J., Qin, N., Zhang, H., Yang, R., Xiang, B., & Wei, Q. (2016) · Scientific Reports · doi:10.1038/srep24346 · Cited by 14
Tiberio, L., Laffranchi, M., Zucchi, G., Salvi, V., Schioppa, T., Sozzani, S., Prete, A. D., & Bosisio, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1360291 · Cited by 13
Galactokinase Is a Novel Modifier of Calcineurin-Induced Cardiomyopathy in Drosophila
Lee, T. E., Yu, L., Wolf, M. J., & Rockman, H. A. (2014) · Genetics · doi:10.1534/genetics.114.166777 · Cited by 13
Wei, J., Li, L., Yao, S., Yang, S., Zhou, S., Liu, X., Du, M., & An, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01312 · Cited by 13
Shinzawa, M., Konno, H., Qin, J., Akiyama, N., Miyauchi, M., Ohashi, H., Miyamoto‐Sato, E., Yanagawa, H., Akiyama, T., & Inoue, J. (2015) · Scientific Reports · doi:10.1038/srep10758 · Cited by 13
NFAT1 Regulates Systemic Autoimmunity through the Modulation of a Dendritic Cell Property
Chae, C.-S., Kim, G.-C., Park, E. S., Lee, C., Verma, R. P., Cho, H., Jun, C., Yoo, Y. J., & Im, S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700882 · Cited by 11
Renal tubular expression of Toll‐like receptor 4 in cyclosporine nephrotoxicity
Lim, B. J., Hong, S. W., & Jeong, H. J. (2009) · Apmis · doi:10.1111/j.1600-0463.2009.02514.x · Cited by 11
Maya-Aguirre, C. A., Torres, A., Gutiérrez-Castañeda, L. D., Salazar, L. M., Abreu‐Villaça, Y., Manhães, A. C., & Arenas, N. E. (2024) · Environmental Science and Pollution Research · doi:10.1007/s11356-024-34185-x · Cited by 10
Vichare, R., Crelli, C. V., Liu, L., Das, A. C., McCallin, R., Zor, F., Külahçı, Y., Gorantla, V. S., & Janjic, J. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102372 · Cited by 10
Calcineurin B stimulates cytokine production through a CD14‐independent Toll‐like receptor 4 pathway
Wu, W., Chen, Q., Geng, F., Li, T., Yang, R., Yang, J.-J., Zhang, H., Jia, Z., & Wei, Q. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.91 · Cited by 10
Murata, K., Motomura, Y., Tanaka, T., Kanno, S., Yano, T., Onimaru, M., Shimoyama, A., Nishio, H., Sakai, Y., Oh‐hora, M., et al. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.13002 · Cited by 10
Effects of Toll-Like Receptor Signals in T-Cell Neoplasms
Morrison, C., Baer, M. R., Zandberg, D. P., Kimball, A. S., & Dávila, E. (2011) · Future Oncology · doi:10.2217/fon.10.185 · Cited by 11
Staley, H. A., Jernigan, J. E., Bolen, M. L., Titus, A. M., Neighbarger, N., Cole, C., Menees, K. B., Wallings, R. L., & Tansey, M. G. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03271-9 · Cited by 9
“Many of these pathways involve calcium signaling, and the calcineurin cascade which in macrophages has been shown to down-regulate TLR mediated activation pathways [43].”
BackgroundTargeting calcineurin induces cardiomyocyte proliferation in adult mice
Lam, N. T., Nguyen, N. U. N., Ahmed, M. S., Hsu, C., Coronado, P. E. R., Li, S., Menendez-Montes, I., Thet, S., Elhelaly, W. M., Xiao, F., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00098-6 · Cited by 9
Thaçi, D., Kaufmann, R., Bieber, T. R. M., Hanfland, J., Hauffe, S., Koehne‐Voss, S., & Waldmeier, F. (2010) · Dermatology · doi:10.1159/000320125 · Cited by 8
Abdul, M., Charron, D. J., & Haziot, A. (2008) · Transplantation · doi:10.1097/tp.0b013e3181861f1d · Cited by 7
Zmonarski, S. C., Kościelska−Kasprzak, K., Banasik, M., Myszka, M., Żabińska, M., Madziarska, K., Mazanowska, O., Krajewska, M., Boratyńska, M., & Klinger, M. (2016) · Transplantation Proceedings · doi:10.1016/j.transproceed.2016.03.002 · Cited by 7
Bommireddy, R., Bueno, O. F., Martin, J.-C. E., Ormsby, I., Chen, H., Gard, C., Molkentin, J. D., Boivin, G. P., Babcock, G. F., & Doetschman, T. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04015.x · Cited by 6
Sakai, H., Tanaka, Y., Tanaka, A., & Ohdan, H. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16288 · Cited by 5
Kimura, T., Sekido, M., Iio, A., Chimura, N., SHIBATA, S., Kamishina, H., Kamishina, H., & Maeda, S. (2013) · Veterinary Dermatology · doi:10.1111/vde.12017 · Cited by 5
Crofts, K. F., Holbrook, B. C., Soto‐Pantoja, D. R., Ornelles, D. A., & Alexander‐Miller, M. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00540 · Cited by 5
Mazidi, Z., Wieser, M., Sp̂înu, N., Weidinger, A., Kozlov, A. V., Vuković, K., Wellens, S., Murphy, C., Singh, P., Lagares, L. M., et al. (2024) · Toxicology in Vitro · doi:10.1016/j.tiv.2024.105954 · Cited by 4
Abdelwahab, S. F., Mohammed, M. M., Okasha, A., Naiem, A. H. A., Mohamed, R. F., & Mohamed, H. A. (2022) · Current Molecular Medicine · doi:10.2174/1566524022666220106154111 · Cited by 3
Precision attack on calcineurin in macrophages: a new anti‐inflammatory weapon
Schultze, J. L. (2014) · The EMBO Journal · doi:10.1002/embj.201488178 · Cited by 3
Targeting Acute Islet Inflammation to Preserve Graft Mass and Long-Term Function
Darden, C. M., Vasu, S., Kumano, K., Naziruddin, B., & Lawrence, M. C. (2019) · OBM Transplantation · doi:10.21926/obm.transplant.1901043 · Cited by 3
Pouil, S., Rigaudeau, D., Lee, B.-H., Segret, E., Desgranges, A., D’Ambrosio, J., François, Y., Boudinot, P., Duchaud, É., Phocas, F., et al. (2025) · BMC Genomics · doi:10.1186/s12864-025-12231-3 · Cited by 2
Elzokm, S. S., Fouda, M. A., Moneim, R. A. A., & El‐Mas, M. M. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13526 · Cited by 2
Hußner, J., Sünwoldt, J., Seibert, I., Gliesche, D. G., & zu Schwabedissen, H. E. M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.05.020 · Cited by 1
Explanation of Metastasis by Homeostatic Inflammation
Maru, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-1757-7_15 · Cited by 1
Zaid, M. (2011) · uO Research (University of Ottawa) · doi:10.20381/ruor-4501
The Innate Response to a Transplanted Organ
Goldstein, D. R., & Turka, L. A. (2010) · Wiley eBooks · doi:10.1002/9781444355628.ch5
EXPRESSION AND ACTIVITIES OFN-MYRISTOYLTRANSFERASE AND CALCINEURIN IN NORMAL AND INFLAMED LUNGS
Charavaryamath, C., Lemieux, H. D., Suri, S. S., Selvakumar, P., Sharma, R. K., & Singh, B. (2009) · Experimental Lung Research · doi:10.3109/01902140902870741
Explanation of Metastasis by Homeostatic Inflammation
Maru, Y. (2016) · Springer eBooks · doi:10.1007/978-4-431-56024-1_15
Tschöpe, C., Pauschinger, M., Schultheiß, H., Heimesaat, M. M., Bereswill, S., Westermann, D., Jäger, S., & Sobirey, M. (2013)
Brenner, S. R. (2019) · OBM Geriatrics · doi:10.21926/obm.geriatr.1901035
Maru, Y. (2016) · Springer eBooks · doi:10.1007/978-4-431-56024-1_8
Maru, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-1757-7_8
Unlocking the therapeutic potential of the NFAT pathway in kidney diseases
Shreya, S., Dagar, N., & Gaikwad, A. B. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04033-x
Thykamine™: A New Player in the Field of Anti-Inflammatory Drugs
Lynde, C. W., Flamand, L., McCarty, V., & Sampalis, J. S. (2025) · Biomedicines · doi:10.3390/biomedicines13122938
Metadata
- Authors
- Kang, Y. J., Kusler, B., Otsuka, M., Hughes, M., Suzuki, N., Suzuki, S., Yeh, W.-C., Akira, S., Han, J., & Jones, P. P.
- Affiliations
- Stanford University (US)
- Scripps Research Institute (US)
- University Health Network (CA)
- Research Institute for Microbial Diseases, The University of Osaka (JP)
- Corresponding author
- Kusler, Brenda
- Hughes, Michael
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-10-01
- Volume
- 179
- Issue
- 7
- Pages
- 4598-4607
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2168532652
- Cited by
- 104
- References
- 61
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 1 · 2022: 4 · 2021: 6 · 2020: 5 · 2019: 9 · 2018: 3 · 2017: 5 · 2016: 8 · 2015: 4 · 2014: 8 · 2013: 6 · 2012: 8
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Yale University
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- calcineurin, Toll-like receptors, macrophages, innate immunity, NF-κB signaling, MAPK signaling, MyD88, TRIF, TLR2, TLR4, TLR3, TLR9, IκBα degradation, TNF-alpha production, cyclosporine, FK506, protein phosphatase
- MeSH terms
- Animals, Cell Line, Enzyme Activation, Phosphorylation, Signal Transduction, NF-kappa B, Interferon-beta, Receptors, Tumor Necrosis Factor, Calcineurin, Adaptor Proteins, Vesicular Transport, RNA, Small Interfering, Interferon Regulatory Factor-3, Toll-Like Receptors, Mice, I-kappa B Kinase, Myeloid Differentiation Factor 88, Calcineurin Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review